Sana Biotechnology 株価情報 (NASDAQ: SANA)

最新ニュース Sana Biotechnology (NASDAQ:SANA) 株価情報

Sana Biotechnology

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.

Sana Biotechnology Inc

SANAI HEALTH IND GROUP CO by SANAI HEALTH IND GROUP CO LTD.

Sanara MedTech Inc

Sanarco Funds Inc

Sanatana Resources Inc

SANATANA RESOURCES INC by Sanatana Resources Inc.

News

Telix Says Brazilian Health Regulatory Agency ANVISA Has Approved Illuccix  Prostate Cancer Imaging Agent

XOMA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.30) by 50 percent. This is a 75.94 percent increase over losses of $(1.87) per share from the same period last year. The company reported quarterly sales of $8.71 million which missed the analyst consensus estimate of $8.75 million by 0.43 percent. This is a 384.11 percent increase over sales of $1.80 million the same period last year.

Earnings

Earnings Misses

XOMA

XOMA Q4 2024 GAAP EPS $(0.45) Misses $(0.30) Estimate, Sales $8.71M Miss $8.75M Estimate

Technology giant Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) has been rumored to be working on foldable devices such as smartphones<a href="https://www.benzinga.com/news/24/02/36988960/foldable-apple-iphone-could-be-coming-what-investors-should-know"> for several years.</a>
A new report says the company's first foldable could be here as early as 2026.
What Happened: In the most recently reported<a href="https://www.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever"> first quarter</a>, Apple saw its iPhone revenue fall from $69.7 billion to $69.1 billion on a year-over-year basis.
Hoping for new signs of growth, Apple has launched the more affordable iPhone 16e and could have more news on the way about a foldable phone to win over investors.
GF Securities analyst Jeff Pu said Apple's first foldable is coming in 2026 and it could help the company recover from its lower-than-expected iPhone sales, as <a href="https://9to5mac.com/2025/03/17/iphone-apple-first-foldable/">reported </a>by 9to5Mac.
Pu said Apple's smartphone market will "recover in 2026" with two new foldable devices. The analyst said at least one of the devices will enter mass production in the second half of 2026 with Apple already working with suppliers.
The analyst said the foldable device "remains on track" to reach "P1" next month, an early stage of prototyping for Apple.
The report from Pu falls in line with other analysts like Ming-Chi Kuo who said the company's first foldable iPhone coming in 2026 could <a href="https://www.benzinga.com/media/25/03/44165398/apples-foldable-ai-iphone-could-cost-over-2000-20-million-units-shipped-by-2027-analyst">cost $2,000 or more.</a>
Along with a foldable iPhone, Apple is also working on a foldable device with an 18-inch screen, which would likely be a new Mac or iPad.
Read Also: <a href="https://www.benzinga.com/tech/25/02/43959549/exclusive-apple-iphone-16e-a-smart-buy-or-overpriced-heres-what-34-think">EXCLUSIVE: Apple iPhone 16e – A Smart Buy Or Overpriced? Here&#8217;s What 34% Think</a>
Why It's Important: Apple's rollout of Apple Intelligence AI features on the iPhone 16 may have underwhelmed users and led to fewer upgrades from customers.
With users waiting for more features, the question around a foldable iPhone quickly becomes whether customers are ready to pay a premium for this technology.
A foldable smartphone has been in the works for Apple for years with CEO Tim Cook speaking to engineers about a foldable iPhone back in 2018, suggesting it as a key priority for the future.
Competitors including Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>), Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google and Motorola have already released foldable phones.
While foldable smartphones make up a small percent of the overall smartphone market, Apple entering the space could serve as a true test for demand and key features available within the technology.
With chatbots becoming more predominantly used and smartphones functioning as more than just a phone, the ability to expand to a larger out-of-pocket device could become a feature consumers turn to and never look back on again.
AAPL Price Action: Apple stock was up 0.24% to $214 at market close Monday versus a 52-week trading range of $164.08 to $260.09. Apple stock is down 12.2% year-to-date in 2025 and up 23.2% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43399315/apples-better-than-feared-guidance-calms-iphone-ai-china-concerns-7-analyst-reactions">Apple&#8217;s &#8216;Better Than Feared&#8217; Guidance Calms iPhone, AI, China Concerns: 7 Analyst Reactions</a></li>
</ul>
Photo: Shutterstock

Tech

Trading Ideas

AAPL

GOOG

GOOGL

SSNLF

Apple Stock Faces Pressure From Declining iPhone Revenue: Could Company's First Foldable Smartphone In 2026 Reverse Course?

MEDIROM Healthcare Obtains New Unsecured Short-term Bank Loan Of $2.4M

Guidance

Merrill Lynch & Strategic Return Notes for Select 10 Index

Maison Solutions Reiterates 2025 Guidance For Revenues Of $120M - $125M, Net Income Positive

The Hartford Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) has outperformed the market over the past 5 years by 11.05% on an annualized basis producing an average annual return of 30.96%. Currently, The Hartford Insurance Gr has a market capitalization of $34.38 billion. 
Buying $100 In HIG: If an investor had bought $100 of HIG stock 5 years ago, it would be worth $359.37 today based on a price of $120.46 for HIG at the time of writing.
<h3>The Hartford Insurance Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742247911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning The Hartford Insurance Gr Stock In The Last 5 Years

Maison Solutions Q3 Sales $34.1M Up From $13.6M YoY

CWCO

Consolidated Water FY24 Total Revenue $134M Down From $180.2M YoY

DALN

DallasNews Q4 EPS $0.74 Up From $(0.41) YoY, Sales $31.09M Down From $33.98M YoY

PITA

Heramba Electric Reveals Receipt Of Nasdaq Notice Regarding Minimum Bid Price Requirement

Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) has outperformed the market over the past 10 years by 1.82% on an annualized basis producing an average annual return of 12.33%. Currently, Ciena has a market capitalization of $9.34 billion. 
Buying $100 In CIEN: If an investor had bought $100 of CIEN stock 10 years ago, it would be worth $325.31 today based on a price of $65.68 for CIEN at the time of writing.
<h3>Ciena's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742247032_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CIEN

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

Kingsway Financial Servs FY24 Sales $109.4M Up From $103.2M YoY

Galiano Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GAU#AMEX">GAU</a>) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.06 by 66.67 percent. This is a 166.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $64.55 million which missed the analyst consensus estimate of $77.00 million by 16.17 percent. This is a 8.46 percent increase over sales of $59.51 million the same period last year.

Galiano Gold Q4 2024 Adj EPS $0.02 Misses $0.06 Estimate, Sales $64.55M Miss $77.00M Estimate

Cenovus Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVE#NYSE">CVE</a>) has outperformed the market over the past 5 years by 31.16% on an annualized basis producing an average annual return of 51.06%. Currently, Cenovus Energy has a market capitalization of $24.87 billion. 
Buying $1000 In CVE: If an investor had bought $1000 of CVE stock 5 years ago, it would be worth $8,298.78 today based on a price of $13.65 for CVE at the time of writing.
<h3>Cenovus Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742246121_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Cenovus Energy 5 Years Ago Would Be Worth Today

<h3>Gainers</h3>
<ul>
<li>Sportsman's Warehouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWH#NASDAQ">SPWH</a>) stock rose 6.7% to $1.12 during Monday's after-market session. The company's market cap stands at $42.5 million. </li>
<li>Lovesac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) shares increased by 4.98% to $16.63. The company's market cap stands at $256.6 million. </li>
<li>Holley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLLY#NYSE">HLLY</a>) shares moved upwards by 4.89% to $2.57. The market value of their outstanding shares is at $305.0 million. As per the press release, Q4 earnings came out 4 days ago. </li>
<li>AMMO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) stock rose 4.89% to $1.5. The market value of their outstanding shares is at $178.1 million. </li>
<li>Cenntro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENN#NASDAQ">CENN</a>) shares moved upwards by 4.77% to $1.01. The company's market cap stands at $31.1 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) stock moved upwards by 4.39% to $0.64. The company's market cap stands at $7.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lazydays Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) shares decreased by 6.7% to $0.68 during Monday's after-market session. The company's market cap stands at $74.8 million. </li>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) stock declined by 5.32% to $7.3. The market value of their outstanding shares is at $49.9 million. </li>
<li>Thunder Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) shares fell 5.06% to $0.17. The company's market cap stands at $8.4 million. </li>
<li>Neo-Concept International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) shares fell 4.99% to $0.39. The market value of their outstanding shares is at $7.8 million. </li>
<li>Emerson Radio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MSN#AMEX">MSN</a>) shares declined by 4.34% to $0.42. The company's market cap stands at $8.8 million. </li>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock declined by 3.8% to $0.63. The company's market cap stands at $6.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AIEV

CENN

GORV

HLLY

LOVE

MTEN

POWW

SPHL

SPWH

VMAR

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Harrow (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) stock moved upwards by 15.8% to $27.0 during Monday's after-market session. The market value of their outstanding shares is at $961.5 million. The company's, Q4 earnings came out today. </li>
<li>Coeptis Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COEP#NASDAQ">COEP</a>) shares moved upwards by 14.7% to $9.75. The company's market cap stands at $31.6 million. </li>
<li>Nanobiotix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTX#NASDAQ">NBTX</a>) stock moved upwards by 14.37% to $3.66. The company's market cap stands at $173.5 million. </li>
<li>Enzo Biochem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENZ#NYSE">ENZ</a>) stock increased by 8.48% to $0.51. The market value of their outstanding shares is at $26.6 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) stock increased by 7.93% to $0.62. The market value of their outstanding shares is at $44.1 million. </li>
<li>Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) stock rose 6.31% to $0.47. The market value of their outstanding shares is at $11.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kyverna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYTX#NASDAQ">KYTX</a>) shares fell 20.5% to $2.02 during Monday's after-market session. The market value of their outstanding shares is at $87.1 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock decreased by 17.93% to $0.14. The market value of their outstanding shares is at $2.5 million. </li>
<li>Hyperfine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>) shares declined by 12.5% to $1.12. The company's market cap stands at $86.7 million. As per the press release, Q4 earnings came out today. </li>
<li>Capstone Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPS#NASDAQ">CAPS</a>) shares declined by 9.4% to $2.7. The company's market cap stands at $3.8 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares decreased by 7.77% to $0.49. The market value of their outstanding shares is at $2.3 million. </li>
<li>BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) stock declined by 7.7% to $0.33. The company's market cap stands at $19.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BCAB

CAPS

COEP

CTOR

ENTO

HROW

HYPR

KYTX

NBTX

SNSE

VRPX

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) stock moved upwards by 15.5% to $1.19 during Monday's after-market session. The market value of their outstanding shares is at $19.3 million. </li>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares increased by 9.5% to $0.72. The company's market cap stands at $259.7 million. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) shares moved upwards by 7.42% to $0.76. The market value of their outstanding shares is at $16.9 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) shares increased by 6.45% to $4.29. The company's market cap stands at $145.3 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock increased by 4.98% to $0.51. The company's market cap stands at $100.8 million. As per the press release, Q4 earnings came out today. </li>
<li>Byrna Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYRN#NASDAQ">BYRN</a>) shares increased by 4.96% to $20.29. The company's market cap stands at $459.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) shares fell 13.2% to $0.99 during Monday's after-market session. The company's market cap stands at $150.5 million. The company's, Q4 earnings came out today. </li>
<li>Callan Jmb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJMB#NASDAQ">CJMB</a>) stock declined by 9.55% to $5.31. The market value of their outstanding shares is at $23.5 million. </li>
<li>Ocean Power Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#AMEX">OPTT</a>) shares decreased by 6.4% to $0.57. The company's market cap stands at $83.7 million. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) shares declined by 6.4% to $0.21. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) stock fell 5.75% to $0.33. The market value of their outstanding shares is at $9.9 million. </li>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) shares declined by 5.08% to $0.13. The company's market cap stands at $3.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREB

BYRN

CJMB

DXST

EFSH

LNZA

MCRP

NRGV

OPTT

SFHG

WATT

12 Industrials Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) stock increased by 13.0% to $7.89 during Monday's after-market session. The market value of their outstanding shares is at $634.3 million. The company's, Q4 earnings came out today. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) shares moved upwards by 11.37% to $5.19. The market value of their outstanding shares is at $84.8 million. </li>
<li>Optical Cable (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCC#NASDAQ">OCC</a>) stock moved upwards by 11.24% to $3.66. The company's market cap stands at $30.0 million. </li>
<li>Diginex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) stock increased by 6.04% to $68.04. The company's market cap stands at $1.5 billion. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock increased by 5.29% to $1.79. The market value of their outstanding shares is at $3.3 million. </li>
<li>PicoCELA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) stock rose 4.99% to $0.84. The company's market cap stands at $20.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) shares fell 10.5% to $0.94 during Monday's after-market session. The market value of their outstanding shares is at $1.3 million. </li>
<li>AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) shares decreased by 6.2% to $11.82. The market value of their outstanding shares is at $143.9 million. The company's, Q4 earnings came out 3 days ago. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares decreased by 5.01% to $0.21. The market value of their outstanding shares is at $14.1 million. </li>
<li>Smith Micro Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares decreased by 4.88% to $0.78. The company's market cap stands at $13.8 million. The company's, Q4 earnings came out 4 days ago. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) shares decreased by 4.58% to $1.24. The company's market cap stands at $57.1 million. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock decreased by 4.51% to $0.07. The market value of their outstanding shares is at $1.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEYE

AIRE

DGLY

DGNX

GRYP

KODK

PCLA

SMSI

XTKG

12 Information Technology Stocks Moving In Monday's After-Market Session

Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.06) by 533.33 percent. This is a 123.53 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $44.47 million which missed the analyst consensus estimate of $46.64 million by 4.66 percent. This is a 30.05 percent increase over sales of $34.19 million the same period last year.

AMPS

Altus Power Q4 2024 GAAP EPS $(0.38) Misses $(0.06) Estimate, Sales $44.47M Miss $46.64M Estimate

Patel will be leaving his position on Crown Castle's Board of Directors, effective March 17, 2025.
&nbsp;

Management

Crown Castle Appointms Sunit Patel As Executive Vice President And CFO, Effective April 1, 2025

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA

Health Care

General

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type 1 Diabetes, CS Diagnostics (OTCQB: CSDX) Cancer Therapy – CURR, TPET, PRSO, PNPN.V, EONR – Plus More Stocks Under $2 Inside See Now!

Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation

Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

Commodities

Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Comments

Sana Biotechnology

ニュース

最新ニュース Sana Biotechnology (NASDAQ:SANA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル